Maynard Um
-
-
-
-
-
-
-
BridgeBio and Community Partners Launch Nationwide ATTR-CM Education Effort Ahead of World Amyloidosis Day
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on BridgeBio Pharma (BBIO), Updates Estimates
-
-
-
-
-
-
-
BridgeBio raises $1 billion in convertible preferred equity
-
-
-
-
-
-
-
BridgeBio shares new acoramidis data showing cardiovascular benefits
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
-
-
-
-
-
-
-
Mizuho on BridgeBio Pharma (BBIO): 'Not Best Case but Still Good Outcome Relative to Street'
-
470,308 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


